ASSAYS MEDICAL DIAGNOSTIC

Brand Owner (click to sort) Address Description
GENECENTRIC GENECENTRIC THERAPEUTICS, INC. 100 Capitola Dr. Suite 275 Durham NC 27713 Assays for the medical diagnostic, prognostic and predictive testing of tumors; Medical diagnostic kits containing assays for the medical diagnostic, prognostic and predictive testing of tumors; Biological preparations for the treatment of cancer; Diagnostic preparations for medical purposes; Diagnostic kits comprised of diagnostic reagents and diagnostic assays for testing tissue samples for use in cancer detection, analysis and prognosis; Medical diagnostic reagents; Clinical diagnostic reagents for medical use; Diagnostic kits consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing for medical purposes; Medical diagnostic assays for testing body fluids for medical and prognostic purposes; Medical diagnostic reagents and assays for testing tissue samples; Enzyme preparations for medical purposes; Biological preparations for the detection, diagnosis and monitoring of cancer;
LSP GENECENTRIC THERAPEUTICS, INC. 100 Capitola Dr. Suite 275 Durham NC 27713 Assays for the medical diagnostic, prognostic and predictive testing of tumors; and medical diagnostic kits containing assays for the medical diagnostic, prognostic and predictive testing of tumors;LUNG SUBTYPE PLATFORM;
LSP GENECENTRIC THERAPEUTICS, INC. 100 Capitola Dr. Suite 275 Durham NC 27713 Assays for the medical diagnostic, prognostic and predictive testing of tumors; and medical diagnostic kits containing assays for the medical diagnostic, prognostic and predictive testing of tumors;
PURIST GENECENTRIC THERAPEUTICS, INC. 100 Capitola Dr. Suite 275 Durham NC 27713 Assays for the medical diagnostic, prognostic and predictive testing of tumors; diagnostic preparations for medical purposes; medical diagnostic reagents; medical diagnostic reagents and assays for testing tissue samples; biological preparations for the detection, diagnosis, subtyping and monitoring of cancer;Medical testing services; medical testing for diagnostic and treatment option purposes; medical services, namely, cell and gene therapy research; providing molecular genetics and genomics testing and reporting services in the field of biomarkers for the diagnosis, prognosis, treatment or management of cancer; providing a website and information in the field of medical research and scientific research in the fields of tumor biology, oncology, genetic therapy research, and diagnosis and treatment of cancers; provision of health care services, namely, providing oncological testing reports to physicians;Providing medical, scientific and pharmaceutical research services; providing medical research and scientific research information in the field of oncology; providing medical and scientific research services in the field of cancer diagnosis, prognosis, therapy, prevention, treatment and patient management; providing research and development services in the oncology; research and development in the field of RNA expression, namely, cancer biology; research and development services for others, namely, research and development of assays for oncological testing and diagnostic purposes; scientific research in the field of RNA expression analysis and reporting; providing laboratory research services in the field of pancreatic cancer; research and development in the fields of biomarker discovery and validation; medical and scientific research in the field of biomarker discovery in cancer patients; pharmaceutical and medical research in the field of survival outcomes and standard of care research; medical research featuring the identification and validation of cancer related biomarkers and RNA expression for use in improved patient outcomes;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. A bacterial ?1,3-fucosyltransferase gene and deduced amino acid sequence is provided. The gene is useful for preparing ?1,3-fucosyltransferase polypeptide, and active fragment thereof, which can be used in the production of oligosaccharides such as Lewis X, Lewis Y, and siayl Lewis X, which are structurally similar to certain tumor-associated carbohy-drate antigens found in mammals. These product glycoconjugates also have research and diagnostic utility in the development of assays to detect mammalian tumors. In addition the polypeptide of the invention can be used to develop diagnostic and research assays to determine the presence of H. pylori in human specimens.